Long-term Serological Evaluation of Patients with Cystic Echinococcosis Treated with Benzimidazole Carbamates

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 2002 Aug 29

PMID 12197890

Citations 27

Authors

R Rigano

S Ioppolo

E Ortona

P Margutti

E Profumo

M D Ali

B Di Vico

A Teggi

A Siracusano

Affiliations

Soon will be listed here.

Abstract

Seeking better immunological markers indicating the long-term outcome of cystic echinococcosis (CE) after chemotherapy we studied 23 patients receiving albendazole, clinically followed for 8 years, and grouped ultrasonographically according to therapeutic outcome. Antibody responses against a partially purified fraction of hydatid fluid (HFF) and antigen B (AgB) were evaluated by indirect haemagglutination (IHA), ELISA and immunoblotting (IB). Although IHA titres varied over the course of treatment, differences in mean antibody titres to HFF between groups were significant only at 4 years (P = 0.031). IgG isotype expression remained unchanged during follow-up whereas IgE expression decreased in patients with cured or stable disease. AgB disclosed higher IgG4 expression (P < 10(-4); P = 0.025) and lower IgG1 expression than HFF (P < 10(-4); P = 0.022). IHA antibody titres were higher in patients with progressive than in those with cured or stable disease, even in those with the same cyst type. ELISA isotype profiles differed between groups, particularly for type CE 3, 4 and 5 cysts: higher serum IgG1 and IgG3, lower IgG4 and IgE in patients with cured or stable disease. Although combined serological testing provides scarce information on the long-term outcome of CE after chemotherapy it may be useful for reviewing in a retrospective study the outcome of a cyst and for assessing the host-parasite relationship.

Citing Articles

Prevesical hydatid cyst: A case report.

Mesfin T, Taha M, Sahiledengle B, Nigusu F, Seyoum K, Geta G Clin Case Rep. 2023; 11(11):e8243.

PMID: 38028035 PMC: 10658573. DOI: 10.1002/ccr3.8243.

Bacterial Infection of an Alveolar Echinococcus Cyst from Septicemia: A Case Report and Review of the Literature.

Buttenschoen J, Pavel V, Mehrl A, Michels B, Albaladejo Fuertes S, Seydel B Medicina (Kaunas). 2023; 59(10).

PMID: 37893546 PMC: 10608314. DOI: 10.3390/medicina59101828.

Characterization of protein cargo of Echinococcus granulosus extracellular vesicles in drug response and its influence on immune response.

Nicolao M, Rodriguez Rodrigues C, Coccimiglio M, Ledo C, Docena G, Cumino A Parasit Vectors. 2023; 16(1):255.

PMID: 37516852 PMC: 10387209. DOI: 10.1186/s13071-023-05854-6.

Case Series of Cystic Echinococcosis Over a Twelve-year Period at Sultan Qaboos University Hospital, Oman.

Hassan K, Al Balushi A, Wazir H, Al Adawi B Oman Med J. 2023; 38(2):e482.

PMID: 37009206 PMC: 10039982. DOI: 10.5001/omj.2023.61.

Detection of sensu lato cysts and seroprevalence of cystic echinococcosis in cattle and camels in Maiduguri Abattoir.

Yakubu R, Nock I, Ndams I, Luka S, Yaro C, Alkazmi L J Parasit Dis. 2022; 46(3):876-888.

PMID: 36091268 PMC: 9458832. DOI: 10.1007/s12639-022-01508-z.

References

Ioppolo S, Notargiacomo S, Profumo E, Franchi C, Ortona E, Rigano R . Immunological responses to antigen B from Echinococcus granulosus cyst fluid in hydatid patients. Parasite Immunol. 1996; 18(11):571-8. DOI: 10.1046/j.1365-3024.1996.d01-31.x. View

Franchi C, Di Vico B, Teggi A . Long-term evaluation of patients with hydatidosis treated with benzimidazole carbamates. Clin Infect Dis. 1999; 29(2):304-9. DOI: 10.1086/520205. View

Gadea I, Ayala G, Diago M, Cunat A, de Lomas J . Immunological diagnosis of human hydatid cyst relapse: utility of the enzyme-linked immunoelectrotransfer blot and discriminant analysis. Clin Diagn Lab Immunol. 2000; 7(4):549-52. PMC: 95911. DOI: 10.1128/CDLI.7.4.549-552.2000. View

Ortona E, Siracusano A, Castro A, Rigano R, Muhlschlegel F, Ioppolo S . Use of a monoclonal antibody against the antigen B of Echinococcus granulosus for purification and detection of antigen B. Appl Parasitol. 1995; 36(3):220-5. View

Di Felice G, Pini C, Afferni C, VICARI G . Purification and partial characterization of the major antigen of Echinococcus granulosus (antigen 5) with monoclonal antibodies. Mol Biochem Parasitol. 1986; 20(2):133-42. DOI: 10.1016/0166-6851(86)90025-3. View

Shambesh M, Craig P, Wen H, Rogan M, Paolillo E . IgG1 and IgG4 serum antibody responses in asymptomatic and clinically expressed cystic echinococcosis patients. Acta Trop. 1997; 64(1-2):53-63. DOI: 10.1016/s0001-706x(96)00637-7. View

Rogan M, Craig P, Zeyhle E, Romig T, Lubano G, Deshan L . Evaluation of a rapid dot-ELISA as a field test for the diagnosis of cystic hydatid disease. Trans R Soc Trop Med Hyg. 1991; 85(6):773-7. DOI: 10.1016/0035-9203(91)90451-4. View

MATOSSIAN R, Awar G, Radwan H, Craig P, Meshefedjian G . Immune status during albendazole therapy for hydatidosis. Ann Trop Med Parasitol. 1992; 86(1):67-75. DOI: 10.1080/00034983.1992.11812632. View

Rigano R, Profumo E, Ioppolo S, Notargiacomo S, Ortona E, Teggi A . Immunological markers indicating the effectiveness of pharmacological treatment in human hydatid disease. Clin Exp Immunol. 1995; 102(2):281-5. PMC: 1553412. DOI: 10.1111/j.1365-2249.1995.tb03778.x. View

10.

Guerri M, Davila M, Rodriguez M, Nieto F, Ladron de Guevara C . [Utility of IgG subclasses in the diagnosis and follow up of hydatidosis]. Enferm Infecc Microbiol Clin. 2000; 18(6):262-6. View

11.

Lacey E . Mode of action of benzimidazoles. Parasitol Today. 1990; 6(4):112-5. DOI: 10.1016/0169-4758(90)90227-u. View

12.

Ravinder P, Parija S, Rao K . Evaluation of human hydatid disease before and after surgery and chemotherapy by demonstration of hydatid antigens and antibodies in serum. J Med Microbiol. 1997; 46(10):859-64. DOI: 10.1099/00222615-46-10-859. View

13.

Craig P . Detection of specific circulating antigen, immune complexes and antibodies in human hydatidosis from Turkana (Kenya) and Great Britain, by enzyme-immunoassay. Parasite Immunol. 1986; 8(2):171-88. DOI: 10.1111/j.1365-3024.1986.tb00843.x. View

14.

Daeki A, Craig P, Shambesh M . IgG-subclass antibody responses and the natural history of hepatic cystic echinococcosis in asymptomatic patients. Ann Trop Med Parasitol. 2000; 94(4):319-28. DOI: 10.1080/00034983.2000.11813546. View

15.

Bombardieri S, Giordano F, INGRAO F, Ioppolo S, Siracusano A, VICARI G . An evaluation of an agar gel diffusion test with crude and purified antigens in the diagnosis of hydatid disease. Bull World Health Organ. 1974; 51(5):525-30. PMC: 2366308. View

16.

Wen H, Craig P . Immunoglobulin G subclass responses in human cystic and alveolar echinococcosis. Am J Trop Med Hyg. 1994; 51(6):741-8. DOI: 10.4269/ajtmh.1994.51.741. View

17.

McVie A, Ersfeld K, Rogan M, Craig P . Expression and immunological characterisation of Echinococcus granulosus recombinant antigen B for IgG4 subclass detection in human cystic echinococcosis. Acta Trop. 1997; 67(1-2):19-35. DOI: 10.1016/s0001-706x(97)00056-9. View

18.

Aceti A, Pennica A, Teggi A, Fondacaro L, Caferro M, Leri O . IgG subclasses in human hydatid disease: prominence of the IgG4 response. Int Arch Allergy Immunol. 1993; 102(4):347-51. DOI: 10.1159/000236582. View

19.

Lightowlers M, Liu D, Haralambous A, Rickard M . Subunit composition and specificity of the major cyst fluid antigens of Echinococcus granulosus. Mol Biochem Parasitol. 1989; 37(2):171-82. DOI: 10.1016/0166-6851(89)90149-7. View

20.

. Guidelines for treatment of cystic and alveolar echinococcosis in humans. WHO Informal Working Group on Echinococcosis. Bull World Health Organ. 1996; 74(3):231-42. PMC: 2486920. View